Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test may guide chemo decisions for advanced breast cancer

NCT ID NCT01349842

First seen Nov 25, 2025 · Last updated Jun 18, 2026 · Updated 26 times

Summary

This study looked at whether measuring circulating tumor cells (CTCs) in the blood can help doctors decide when to switch chemotherapy for women with metastatic breast cancer that has worsened after two prior treatments. The trial involved 265 women and compared standard care with CTC-guided treatment decisions. The goal was to see if this approach improves overall survival and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Georges Francois Leclerc

    Dijon, 21079, France

  • Chu Limoges

    Limoges, 87042, France

  • Clinique Victor Hugo

    Le Mans, 72000, France

  • Hopital Saint Louis

    Paris, 75475, France

  • Institut Curie

    Paris, 75005, France

  • Institut Rene Huguenin Curie

    Saint-Cloud, 92210, France

  • Institut de Canacerologie de L'Ouest

    Saint-Herblain, 44805, France

Conditions

The condition(s) this trial relates to.

breast carcinoma invasive ductal breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.